Work

Propylene Glycol Alginate Sodium Sulfate (PSS): The First Oral Heparinoid Marine Drug—A Pharmacological and Clinical Review

Year: 2026
Type: article
Abstract: Propylene glycol alginate sodium sulfate (PSS) is the first oral heparinoid marine drug, derived from brown algal alginic acid and marketed in 1986. Its core pharmacology, including anticoagulation, lipid-lowering, microcirculation improvement, and neuroprotection, makes it an affordable oral option for chronic ischemic cardiovascular and cerebrovascular diseases. Pharmacological studies have also revealed anti-inflammatory, anti-fibrotic, anti-metastatic, and FGF/FGFR-activating effects. Notably, these activities can be independently modulated by molecular weight and M/G ratio, enabling activity-specific structural optimization, guiding the development of safer derivatives. This review summarizes PSS’s R&D, mechanisms, clinical applications, and safety, aiming to inform precision medication strategies and inspire similar drug development.
Language: English
Subfield: Aquatic Science
Open Access status: diamond
OpenAlex ID: W7225893400
FWCI:
Cites: 23
Cited by:
Related to: 10